This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fishman, P. Articles by Vagman, L. Search for Related Content PubMed PubMed Citation Articles by Fishman, P. Articles by Vagman, L.

Adenosine and Other Low Molecular Weight Factors Released by Muscle Cells Inhibit Tumor Cell Growth¹

Laboratory of Clinical and Tumor Immunology, The Felsenstein Medical Research Center, Tel-Aviv University, Rabin Medical Center, Petach-Tikva, 49100, Israel

In this study, we investigated the basis of the resistance of muscles to tumor metastases. We found that a low molecular weight fraction (M_r <3000) of skeletal muscle cell-conditioned medium (MCM) markedly inhibits the proliferation of carcinoma, sarcoma, or melanoma cell lines in vitro. The MCM exerts a cytostatic effect on tumor cell growth and arrests the cells in G₀/G₁ of the cell cycle. However, normal cell proliferation of cells such as bone marrow cells or fibroblasts was found to be refractory to the influence of the MCM. A reduction in melanoma growth was observed in mice treated with the MCM.

Adenosine was identified as one of the active components in the MCM by using high-performance liquid chromatography separations, mass spectra, and nuclear magnetic resonance analyses. At a concentration of 4 µM, equal to that found in the MCM, adenosine inhibits the proliferation of tumor cell lines (Nb2 lymphoma, K-562 leukemia, and LNCaP prostate carcinoma cells) while stimulating the proliferation of normal murine bone marrow cells. By similar methods, additional inhibitory components were detected in the MCM in a molecular mass range of 600–800 Da.

The ability of adenosine and other low molecular weight components to specifically inhibit tumor cell growth in vitro and in vivo may account for the resistance of muscle to tumor metastases.

¹ This work was supported by a grant given by Can-Fite Technologies Ltd., Tel Aviv, Israel.

² To whom requests for reprints should be addressed, at Laboratory of Tumor and Clinical Immunology, The Felsenstein Medical Research Institute, Rabin Medical Center, Petach-Tikva, 49100, Israel. Phone: 972-3-5313488; Fax: 972-9-5313208; E-mail: pfishma@ibm.net.

Received 2/10/98. Accepted 5/14/98.

This article has been cited by other articles:

				P. Yang, Z. Han, P. Chen, L. Zhu, S. Wang, Z. Hua, and J. Zhang A Contradictory Role of A1 Adenosine Receptor in Carbon Tetrachloride- and Bile Duct Ligation-Induced Liver Fibrosis in Mice J. Pharmacol. Exp. Ther., March 1, 2010; 332(3): 747 - 754. [Abstract] [Full Text] [PDF]

				S. Merighi, A. Benini, P. Mirandola, S. Gessi, K. Varani, E. Leung, S. Maclennan, and P. A. Borea A3 Adenosine Receptor Activation Inhibits Cell Proliferation via Phosphatidylinositol 3-Kinase/Akt-dependent Inhibition of the Extracellular Signal-regulated Kinase 1/2 Phosphorylation in A375 Human Melanoma Cells J. Biol. Chem., May 20, 2005; 280(20): 19516 - 19526. [Abstract] [Full Text] [PDF]

				S. Gessi, E. Cattabriga, A. Avitabile, R. Gafa', G. Lanza, L. Cavazzini, N. Bianchi, R. Gambari, C. Feo, A. Liboni, et al. Elevated Expression of A3 Adenosine Receptors in Human Colorectal Cancer Is Reflected in Peripheral Blood Cells Clin. Cancer Res., September 1, 2004; 10(17): 5895 - 5901. [Abstract] [Full Text] [PDF]

				J. Lu, A. Pierron, and K. Ravid An Adenosine Analogue, IB-MECA, Down-Regulates Estrogen Receptor {alpha} and Suppresses Human Breast Cancer Cell Proliferation Cancer Res., October 1, 2003; 63(19): 6413 - 6423. [Abstract] [Full Text] [PDF]

				C. P. Barry and S. E. Lind Adenosine-mediated Killing of Cultured Epithelial Cancer Cells Cancer Res., April 1, 2000; 60(7): 1887 - 1894. [Abstract] [Full Text]